The European Commission will support Ventinova to bring FCV® into the ICU
The European Commission will support us to bring FCV® into the ICU in order to improve ventilation of ICU patients, including COVID-19 patients. With this significant financial grant of 2.5 M€, we are able to further improve our ventilator and to investigate and demonstrate clinical benefits of FCV® in ICU patients.
Ventinova aims to provide highly efficient and harmless respiration for all ventilated patients, including COVID-19 patients, to reduce mortality and hospital stay. We thank the European Innovation Counsel (EIC) for receiving the EIC Accelerator funding through the Horizon 2020 Framework Programme for Research and Innovation.
Back to all news items
Subject: Publication 'Core topics in Airway management' In the new edition of ‘core topics in Airway management’ both Ventrain and Evone are extensively mentioned: Chapter 18 is fully dedicated to Ventrain and Evone (Written by Kirstensen and Michiel de...